Welcome to Medivizor!

You're browsing our sample library. Feel free to continue browsing. You can also sign up for free to receive medical information specific to your situation.

Posted by on Sep 26, 2019 in Lung cancer | 0 comments

In a nutshell

This study investigated the effectiveness of epidermal growth factor (EGF) ointment to treat skin side effects in patients with non-small cell lung cancer (NSCLC) receiving epidermal growth factor receptor (EGFR) inhibitor treatment. Researchers suggested that EGF ointment improves the outcomes and quality of life of these patients.

Some background

EGF is essential for the growth and progression of cancer. Anti-EGF therapy (EGFR inhibitors) such as erlotinib (Tarceva), cetuximab (Erbitux), and afatinib (Giotrif) have been approved for cancer treatment alone or in combination with chemotherapy and/or radiation. 

EGF is also very important for skin balance and wound healing. The most common side effects associated with anti-tumor treatment with anti-EGF are skin conditions. These conditions affect the quality of life of the patient and can be the cause of stopping the treatment. Prior studies showed that EGF ointment is associated with improved outcomes for skin conditions. The effectiveness of this treatment for skin side effects of EGFR inhibitors for patients with cancer is not fully known.

Methods & findings

This study included information about 80 patients with cancer treated with EGFR inhibitors. 9 had pancreatic cancer, 28 had NSCLC, and 43 had colorectal cancer. All patients had moderate to severe skin reactions from the cancer treatment. These patients were assigned to receive placebo (a drug with no effect in the body), EGF ointment in low dose or EGF ointment in high dose. Patients in the EGF group applied ointment 2 times daily. The effectiveness of the ointment was assessed after 2 weeks of treatment and then after every 4 weeks. 

Responses to the treatment were 44.4% in the placebo group, 61.5% in the EGF low dose group and 77.8% in the EGF high dose. Quality of life was assessed for 74 patients. Patients treated with EGF ointment showed significant improvement in emotions and functioning.

The bottom line

This study concluded that EGF ointment improves skin complications in patients with cancer being treated with anti-EGFR drugs.

The fine print

This was a small study. Larger studies are needed for stronger evidence.

Published By :

The Oncologist

Date :

Sep 06, 2019

Original Title :

A Randomized Controlled Trial of Epidermal Growth Factor Ointment for Treating Epidermal Growth Factor Receptor Inhibitor-Induced Skin Toxicities.

click here to get personalized updates